SR

Shakti Rani

Active Director Director DIN 06627118
DIN 06627118 First appointment Jun 2013 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2013
Shareholding value •••• Premium profile

About Shakti Rani

Data last updated:

Shakti Rani is a Director at Britt Pharma Private Limited (since 2013). The company operates in Healthcare. Britt Pharma Private Limited reported revenue of ₹76.8 Lakh (FY 2025).

DIN 06627118
Primary Designation Director
Industry Healthcare
First Appointment 25 Jun 2013
Oldest Company Age 14 yrs
Largest company Britt Pharma Private Limited · ₹76.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Britt Pharma Private Limited U51397DL2011PTC228963
Director25 Jun 20132011₹76.8 Lakh (FY 2025)Active

Board colleagues of Shakti Rani

NameDINCompanyDesignation
Amit Kumar Johari05132326Britt Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Britt Pharma Private Limited
Premium access

Shareholding and investment profile for Shakti Rani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shakti Rani

Shakti Rani currently holds 1 directorship: Britt Pharma Private Limited (Director, since 25 Jun 2013, revenue ₹76.8 Lakh (FY 2025)).

Shakti Rani was first appointed on 25 Jun 2013 as Director at Britt Pharma Private Limited.

The current boards of Shakti Rani's companies include Amit Kumar Johari (Britt Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available